Dynavax Licenses Coley’s Toll-Like Receptor Adjuvant For Hep B Vaccine Candidate Heplisav
This article was originally published in The Pink Sheet Daily
Executive Summary
BLA asking approval of one-month, two-dose vaccine regimen anticipated in second half of 2008.